Meritxell Gironella will lead the Institute's contribution to the project, which is financed by Horizon Europe funding from the European Union’s Mari1
In an important breakthrough in precision medicine and for the approval of cost-effective treatments, the expression of eleven genes is found to make1
The COVID-19 pandemic generated a unique scenario to analyse the psychological impact of global and extreme situations on the population. Now, a stud1
Trial TILs001, which is open to patients with metastatic triple-negative breast cancer, is the first study to assess the safety and efficacy of TILs1
The University of Pennsylvania professor and pioneer in developing cancer therapies using T cells covered the history, current state, and future chal1
The study, published in the journal The Lancet Neurology, compares the cognitive and psychiatric symptoms of patients with those of schizophrenia and1
The project will be carried out by researchers from the IDIBAPS Systems Neurosciences group, led by Mavi Sánchez-Vives.
The grant, worth 150,000 euros over 18 months, will enable the group led by Jaime de la Rocha to improve the prototype of a 24/7 automatic behavioura1
The researchers’ goal is to develop a method to reverse the exhaustion that affects T-cells during protracted battles with tumor cells, preventing th1
